Ikarian Capital, LLC Avrobio, Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.15 - $1.48 $41,172 - $52,986
35,802 Added 4.98%
754,061 $965,000
Q3 2023

Nov 14, 2023
BUY
$0.98 - $1.62 $572,430 - $946,263
584,113 Added 435.43%
718,259 $1.11 Million
Q2 2023

Aug 14, 2023
BUY
$0.58 - $1.31 $77,804 - $175,731
134,146 New
134,146 $127,000
Q4 2020

Feb 12, 2021
SELL
$12.79 - $17.1 $1.6 Million - $2.14 Million
-125,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$12.99 - $19.41 $1.62 Million - $2.43 Million
125,000 New
125,000 $1.63 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email